Remove 2006 Remove 2020 Remove Drug Pricing
article thumbnail

Surprise! Brand-Name Drug Prices Fell (Again) in 2020

Drug Channels

It was another year of unexpected drug price developments. In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. I also review the factors behind declining brand-name drug prices.

article thumbnail

Surprise! Brand-Name Drug Prices Fell (Again) in 2020 (rerun)

Drug Channels

It was another year of unexpected drug price developments. In 2020, brand-name drug net prices dropped for the third consecutive year. Meanwhile, brand-name drug list prices grew at their slowest rate in at least 20 years. I also review the factors behind declining brand-name drug prices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Channels News Roundup, September 2020: FQHCs and 340B, Drug Prices, CVS Health’s Zinc, Telehealth, All-Time Greatest Songs, and 10K on Twitter

Drug Channels

We’ve been squirrelling away these acorns from the mighty Drug Channels oaks: I agree. Brand-name drugs prices keep on dropping It’s official: CVS Health’s Zinc GPO actually exists! Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Autumn is here!

article thumbnail

The Booming Biosimilar Market of 2020 (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. Drug pricing perceptions always seem to lag reality. Click here to see the original post and comments from October 2020. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc.

article thumbnail

The Booming Biosimilar Market of 2020

Drug Channels

What’s more, manufacturers of reference products are cutting drug prices to defend their market shares. Last year, Dr. Scott Gottlieb, a former FDA commissioner, argued that we shouldn’t give up on biosimilars and prematurely regulate prices. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc.

article thumbnail

Drug Pricing Policy in 2021: Four Crucial Consequences of Pharmacy Benefits Today

Drug Channels

When Americans complains about “drug prices,” most are actually complaining about the share of costs they pay—and how those costs are computed. drug channel. Today, I review four crucial issues that the new Congress could tackle to address affordability, patients' out-of-pocket obligations, and prescription prices.

article thumbnail

Drug Pricing Policy in 2021: Four Crucial Consequences of Pharmacy Benefits Today (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. Click here to see the original post and comments from December 2020. drug channel. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.